Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

Dec. 8, 2021, 11:08 a.m. EST · CORRECTED

Merck KGaA invests nearly $700 million into venture capital arm M Ventures

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Merck KGaA ADR (MKKGY)
  • X
    Merck KGaA (MRK)

or Cancel Already have a watchlist? Log In

By Steve Gelsi

This replaces an earlier item that incorrectly reported the company making the investment in M Ventures. It has been corrected.

Merck KGaA /zigman2/quotes/206962101/composite MKKGY -1.33% /zigman2/quotes/209909728/delayed XE:MRK -1.99% said Wednesday it will invest an additional 600 million euros (about $680 million) into its corporate venture capital arm M Ventures over the next five years. That's the third increase in financial commitment announced by the Germany-based science and technology company since M Ventures' inception in 2009. "Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems," said Merck KGaA Chief Executive Belén Garijo.

/zigman2/quotes/206962101/composite
US : U.S.: OTC
$ 43.17
-0.58 -1.33%
Volume: 30,681
Jan. 18, 2022 11:37a
P/E Ratio
29.19
Dividend Yield
0.98%
Market Cap
$95.02 billion
Rev. per Employee
$392,331
loading...
/zigman2/quotes/209909728/delayed
XE : Germany: Xetra
190.00
-3.85 -1.99%
Volume: 410,960
Jan. 18, 2022 5:37p
P/E Ratio
30.72
Dividend Yield
0.74%
Market Cap
€84.28 billion
Rev. per Employee
€328,284
loading...

Get news alerts on Merck KGaA ADR — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.